Rare Bird Alert
This is New Hampshire Audubon’s Rare Bird Alert for Monday, Jan. 22.
Source: unionleader.com
📰 Common Pathway News
Common Pathway News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Common Pathway. Real-time updates on events, politics, business and more.
Lynparza receives Health Canada approval as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Lynparza receives Health Canada approval as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer - read this article along with other careers information, tips and advice on BioSpace
United States United Kingdom Cathy Ammendolea Karen Gelmon Astrazeneca Canada Inc American Society Of Clinical Oncology Annual Meeting
Source: biospace.com
Monadnock Ledger-Transcript - Residents can weigh in on downtown's future
Peterborough residents got their first look at a process they can participate in this summer to put together a vision for the downtown area of Peterborough during an information session on Wednesday.Peterborough is planning a three-day, charette-style...
Danica Melone Planning Department Department Of Public Works Peterborough Greater Downtown Tax Increment Financing Fund Room At Peterborough Town Library Monadnock Alliance For Sustainable Transportation
Source: ledgertranscript.com
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer
AstraZeneca’s supplemental New Drug Application (sNDA) for Lynparza (olaparib) has been accepted and granted Priority Review in the US for the adjuvant treatment of patients with BRCA-mutated (BRCAm) HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery.
United States United Kingdom Daiichi Sankyo Company On Twitter Drug Administration Frontier Science Technology Research Foundation
Source: pressreleasepoint.com
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer
AstraZeneca’s supplemental New Drug Application (sNDA) for Lynparza (olaparib) has been accepted and granted Priority Review in the US for the adjuvant...
United States United Kingdom Daiichi Sankyo Drug Administration Frontier Science Technology Research Foundation Breast International Group
Source: mynewsdesk.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza reduced recurrence risk in breast cancer
Investegate announcements from AstraZeneca PLC, Lynparza reduced recurrence risk in breast cancer
Source: investegate.co.uk
UNILORIN scientists recommend pineapple in COVID-19 management
By Fatima Mohammed-Lawal Ilorin, Jan. 18, 2021 A team of researchers at the University of Ilorin (UNILORIN) have established the capacity of Bromelain derivable from pineapple fruits in the management of COVID-19 cases. According to the University of Ilorin Bulletin issued on Monday, the discovery is in conjunction with Prof. Bamidele Owoeye, the Head, Department of Physiology, and Mr Ahmed Bakare, a Ph.D. candidate at the university. The publication is entitled: “Bromelain reduced Pro-Inflam...
Fatima Mohammed Lawal Gafar Bello Bamidele Owoeye Musa Yakubu Ahmed Bakare Central Research Laboratories
Source: naija247news.com
UNILORIN researchers recommend pineapple in COVID-19 management
UNILORIN researchers recommend pineapple in COVID-19 management On Kindly Share This Story: A team of researchers at the University of Ilorin (UNILORIN) have established the capacity of Bromelain derivable from pineapple fruits in the management of COVID-19 cases. According to the University of Ilorin Bulletin issued on Monday, the discovery is in conjunction with Prof. Bamidele Owoeye, the Head, Department of Physiology, and Mr Ahmed Bakare, a PhD candidate at the university. The publication ...
Gafar Bello Bamidele Owoeye Musa Yakubu Ahmed Bakare Central Research Laboratories University Of Ilorin Bulletin
Source: vanguardngr.com